- Home
- PULM vs TRIB Comparison
PULM vs TRIB Comparison
Compare PULM & TRIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- TRIB
- Stock Information
- Founded
- PULM 2003
- TRIB 1992
- Country
- PULM United States
- TRIB Ireland
- Employees
- PULM N/A
- TRIB N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- TRIB Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PULM Health Care
- TRIB Health Care
- Exchange
- PULM Nasdaq
- TRIB Nasdaq
- Market Cap
- PULM 30.9M
- TRIB 10.7M
- IPO Year
- PULM N/A
- TRIB N/A
- Fundamental
- Price
- PULM $6.20
- TRIB $0.75
- Analyst Decision
- PULM
- TRIB
- Analyst Count
- PULM 0
- TRIB 0
- Target Price
- PULM N/A
- TRIB N/A
- AVG Volume (30 Days)
- PULM 8.4K
- TRIB 59.3K
- Earning Date
- PULM 05-20-2025
- TRIB 05-22-2025
- Dividend Yield
- PULM N/A
- TRIB N/A
- EPS Growth
- PULM N/A
- TRIB N/A
- EPS
- PULM N/A
- TRIB N/A
- Revenue
- PULM $7,806,000.00
- TRIB $59,126,000.00
- Revenue This Year
- PULM N/A
- TRIB $11.63
- Revenue Next Year
- PULM $134.88
- TRIB $10.13
- P/E Ratio
- PULM N/A
- TRIB N/A
- Revenue Growth
- PULM 6.96
- TRIB N/A
- 52 Week Low
- PULM $1.72
- TRIB $0.48
- 52 Week High
- PULM $10.40
- TRIB $3.55
- Technical
- Relative Strength Index (RSI)
- PULM 46.38
- TRIB 56.96
- Support Level
- PULM $5.88
- TRIB $0.72
- Resistance Level
- PULM $6.85
- TRIB $0.84
- Average True Range (ATR)
- PULM 0.30
- TRIB 0.06
- MACD
- PULM 0.02
- TRIB 0.01
- Stochastic Oscillator
- PULM 30.93
- TRIB 63.94
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.
About TRIB Trinity Biotech plc
Trinity Biotech PLC is in the business of developing, manufacturing, and marketing clinical diagnostic products for clinical laboratory and point-of-care sections of the diagnostic market. Its products are used to detect autoimmune, infectious, sexually transmitted diseases, diabetes, and disorders of the liver and intestine. The company also provides raw materials to the life sciences and research industries globally. It markets products under the brand names Recombigen, Unigold, MarBlot, Mardx, Immublot, and others. Geographically, it has two segments namely the Americas, and the Rest of World - Ireland from which it derives a majority of its revenue from the Americas segment.